User menu

Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling.

Bibliographic reference Bosier, Barbara ; Doyen, Pierre ; Brolet, Amandine ; Muccioli, Giulio ; Ahmed, Eman ; et. al. Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling.. In: British Journal of Pharmacology, Vol. 172, no.22, p. 5333-5346 (2015)
Permanent URL http://hdl.handle.net/2078.1/172491
  1. Agarwal Nitin, Pacher Pal, Tegeder Irmgard, Amaya Fumimasa, Constantin Cristina E, Brenner Gary J, Rubino Tiziana, Michalski Christoph W, Marsicano Giovanni, Monory Krisztina, Mackie Ken, Marian Claudiu, Batkai Sandor, Parolaro Daniela, Fischer Michael J, Reeh Peter, Kunos George, Kress Michaela, Lutz Beat, Woolf Clifford J, Kuner Rohini, Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors, 10.1038/nn1916
  2. Alexander Stephen P.H., Benson Helen E., Faccenda Elena, Pawson Adam J., Sharman Joanna L., Spedding Michael, Peters John A., Harmar Anthony J., , The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors : G protein-coupled receptors, 10.1111/bph.12445
  3. Alexander Stephen P.H., Benson Helen E., Faccenda Elena, Pawson Adam J., Sharman Joanna L., McGrath John C., Catterall William A., Spedding Michael, Peters John A., Harmar Anthony J., , The Concise Guide to PHARMACOLOGY 2013/14: Overview : Overview, 10.1111/bph.12444
  4. Alhouayek M., Masquelier J., Cani P. D., Lambert D. M., Muccioli G. G., Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6, 10.1073/pnas.1314017110
  5. Baron Ralf, Binder Andreas, Wasner Gunnar, Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment, 10.1016/s1474-4422(10)70143-5
  6. Berger Julie V, Deumens Ronald, Goursaud Stéphanie, Schäfer Sabrina, Lavand'homme Patricia, Joosten Elbert A, Hermans Emmanuel, Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1, 10.1186/1742-2094-8-33
  7. Blazer L. L., Roman D. L., Chung A., Larsen M. J., Greedy B. M., Husbands S. M., Neubig R. R., Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins, 10.1124/mol.110.065128
  8. Bosier Barbara, Lambert Didier M., Hermans Emmanuel, Reciprocal influences of CB1cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells, 10.1016/j.febslet.2008.10.022
  9. Bosier Barbara, Sarre Sophie, Smolders Ilse, Michotte Yvette, Hermans Emmanuel, Lambert Didier M., Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists, 10.1016/j.neuropharm.2010.07.005
  10. Bouhassira Didier, Lantéri-Minet Michel, Attal Nadine, Laurent Bernard, Touboul Chantal, Prevalence of chronic pain with neuropathic characteristics in the general population : , 10.1016/j.pain.2007.08.013
  11. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L., Quantitative assessment of tactile allodynia in the rat paw, 10.1016/0165-0270(94)90144-9
  12. Chapman V., Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats, 10.1016/s0028-3908(01)00125-3
  13. Costigan Michael, Scholz Joachim, Woolf Clifford J., Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage, 10.1146/annurev.neuro.051508.135531
  14. Desroches J., Bouchard J.-F., Gendron L., Beaulieu P., Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia, 10.1016/j.neuroscience.2013.12.030
  15. Ding Jun, Guzman Jaime N, Tkatch Tatiana, Chen Songhai, Goldberg Joshua A, Ebert Philip J, Levitt Pat, Wilson Charles J, Hamm Heidi E, Surmeier D James, RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion, 10.1038/nn1700
  16. Dworkin Robert H., O'Connor Alec B., Audette Joseph, Baron Ralf, Gourlay Geoffrey K., Haanpää Maija L., Kent Joel L., Krane Elliot J., LeBel Alyssa A., Levy Robert M., Mackey Sean C., Mayer John, Miaskowski Christine, Raja Srinivasa N., Rice Andrew S.C., Schmader Kenneth E., Stacey Brett, Stanos Steven, Treede Rolf-Detlef, Turk Dennis C., Walco Gary A., Wells Christopher D., Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update, 10.4065/mcp.2009.0649
  17. Gallo Alessandro, Dimiziani Andrea, Damblon Jonathan, Michot Benoît, Rieux Anne Des, De Kock Marc, Hermans Emmanuel, Deumens Ronald, Modulation of spinal glial reactivity by intrathecal PPF is not sufficient to inhibit mechanical allodynia induced by nerve crush, 10.1016/j.neures.2015.02.004
  18. Garnier M., Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine, 10.1124/jpet.102.043471
  19. Genzen J. R., McGehee D. S., Short- and long-term enhancement of excitatory transmission in the spinal cord dorsal horn by nicotinic acetylcholine receptors, 10.1073/pnas.1131709100
  20. Goursaud, The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis, 263, 91 (2015)
  21. Govaerts Sophie J, Muccioli Giulio G, Hermans Emmanuel, Lambert Didier M, Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors, 10.1016/j.ejphar.2004.05.023
  22. Grillet N., Pattyn A., Contet C., Kieffer B. L., Goridis C., Brunet J.-F., Generation and Characterization of Rgs4 Mutant Mice, 10.1128/mcb.25.10.4221-4228.2005
  23. Han Ming-Hi, Renthal Willam, Ring Robert H., Rahman Zia, Psifogeorgou Kassi, Howland David, Birnbaum Shari, Young Kathleen, Neve Rachael, Nestler Eric J., Zachariou Venetia, Brain Region Specific Actions of Regulator of G Protein Signaling 4 Oppose Morphine Reward and Dependence but Promote Analgesia, 10.1016/j.biopsych.2009.08.041
  24. Hohmann Andrea G., Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives, 10.1016/s0009-3084(02)00154-8
  25. Hohmann, J Neurophysiol, 81, 575 (1999)
  26. Hsieh Gin C, Pai Madhavi, Chandran Prasant, Hooker Bradley A, Zhu Chang Z, Salyers Anita K, Wensink Erica J, Zhan CenChen, Carroll William A, Dart Michael J, Yao Betty B, Honore Prisca, Meyer Michael D, Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats : Sites of action for CB2 mediated antinociception, 10.1111/j.1476-5381.2010.01046.x
  27. Ibi M., Matsuno K., Matsumoto M., Sasaki M., Nakagawa T., Katsuyama M., Iwata K., Zhang J., Kaneko S., Yabe-Nishimura C., Involvement of NOX1/NADPH Oxidase in Morphine-Induced Analgesia and Tolerance, 10.1523/jneurosci.4136-11.2011
  28. Ibrahim M. M., Deng H., Zvonok A., Cockayne D. A., Kwan J., Mata H. P., Vanderah T. W., Lai J., Porreca F., Makriyannis A., Malan T. P., Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS, 10.1073/pnas.1834309100
  29. Ibrahim M. M., Porreca F., Lai J., Albrecht P. J., Rice F. L., Khodorova A., Davar G., Makriyannis A., Vanderah T. W., Mata H. P., Malan T. P., CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids, 10.1073/pnas.0409888102
  30. Jhaveri M. D., Richardson D., Kendall D. A., Barrett D. A., Chapman V., Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain, 10.1523/jneurosci.3326-06.2006
  31. Kavelaars Annemieke, Eijkelkamp Niels, Willemen Hanneke L.D.M., Wang Huijing, Carbajal Anibal Garza, Heijnen Cobi J., Microglial GRK2: A novel regulator of transition from acute to chronic pain, 10.1016/j.bbi.2011.03.019
  32. Kilkenny Carol, Browne William, Cuthill Innes C, Emerson Michael, Altman Douglas G, Animal research: Reporting in vivo experiments: The ARRIVE guidelines : Animal research: reporting in vivo experiments the ARRIVE guidelines, 10.1111/j.1476-5381.2010.00872.x
  33. La Rana G., Modulation of Neuropathic and Inflammatory Pain by the Endocannabinoid Transport Inhibitor AM404 [N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide], 10.1124/jpet.105.100792
  34. Landry Russell P., Martinez Elena, DeLeo Joyce A., Romero-Sandoval E. Alfonso, Spinal Cannabinoid Receptor Type 2 Agonist Reduces Mechanical Allodynia and Induces Mitogen-Activated Protein Kinase Phosphatases in a Rat Model of Neuropathic Pain, 10.1016/j.jpain.2012.05.013
  35. Lauckner J. E., Hille B., Mackie K., The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins, 10.1073/pnas.0509588102
  36. Leinders Mathias, Knaepen Liesbeth, De Kock Marc, Sommer Claudia, Hermans Emmanuel, Deumens Ronald, Up-regulation of spinal microglial Iba-1 expression persists after resolution of neuropathic pain hypersensitivity, 10.1016/j.neulet.2013.08.062
  37. Lerner Talia N., Kreitzer Anatol C., RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits, 10.1016/j.neuron.2011.11.015
  38. Lim Grewo, Sung Backil, Ji Ru-Rong, Mao Jianren, Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats : , 10.1016/s0304-3959(03)00242-2
  39. Mayer D. J., Mao J., Holt J., Price D. D., Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions, 10.1073/pnas.96.14.7731
  40. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, Guidelines for reporting experiments involving animals: the ARRIVE guidelines : Guidelines for reporting experiments involving animals, 10.1111/j.1476-5381.2010.00873.x
  41. Millns Paul J, Chapman Victoria, Kendall David A, Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones, 10.1038/sj.bjp.0703919
  42. Pan Hui-Lin, Wu Zi-Zhen, Zhou Hong-Yi, Chen Shao-Rui, Zhang Hong-Mei, Li De-Pei, Modulation of pain transmission by G-protein-coupled receptors, 10.1016/j.pharmthera.2007.09.003
  43. Pawson Adam J., Sharman Joanna L., Benson Helen E., Faccenda Elena, Alexander Stephen P.H., Buneman O. Peter, Davenport Anthony P., McGrath John C., Peters John A., Southan Christopher, Spedding Michael, Yu Wenyuan, Harmar Anthony J., , The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands, 10.1093/nar/gkt1143
  44. Petrosino Stefania, Palazzo Enza, de Novellis Vito, Bisogno Tiziana, Rossi Francesco, Maione Sabatino, Di Marzo Vincenzo, Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats, 10.1016/j.neuropharm.2006.08.011
  45. Piomelli D., Hohmann A. G., Seybold V., Hammock B. D., A Lipid Gate for the Peripheral Control of Pain, 10.1523/jneurosci.3475-14.2014
  46. Przewlocki R., Przewlocka B., Opioids in Neuropathic Pain, 10.2174/1381612054865055
  47. Psifogeorgou Kassi, Papakosta Paraskevi, Russo Scott J., Neve Rachael L., Kardassis Dimitris, Gold Stephen J., Zachariou Venetia, RGS9-2 is a negative modulator of μ-opioid receptor function : RGS9-2 modulates μ-opioid receptor responsiveness, 10.1111/j.1471-4159.2007.04812.x
  48. Psigfogeorgou K., Terzi D., Papachatzaki M. M., Varidaki A., Ferguson D., Gold S. J., Zachariou V., A Unique Role of RGS9-2 in the Striatum as a Positive or Negative Regulator of Opiate Analgesia, 10.1523/jneurosci.4146-10.2011
  49. Quartilho Aline, Mata Heriberto P., Ibrahim Mohab M., Vanderah Todd W., Porreca Frank, Makriyannis Alexandros, Malan T. Philip, Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors : , 10.1097/00000542-200310000-00031
  50. Rahman Zia, Schwarz Johannes, Gold Stephen J, Zachariou Venetia, Wein Marc N, Choi Kwang-Ho, Kovoor Abraham, Chen Ching-Kang, DiLeone Ralph J, Schwarz Sigrid C, Selley Dana E, Sim-Selley Laura J, Barrot Michel, Luedtke Robert R, Self David, Neve Rachael L, Lester Henry A, Simon Melvin I, Nestler Eric J, RGS9 Modulates Dopamine Signaling in the Basal Ganglia, 10.1016/s0896-6273(03)00321-0
  51. Richardson, The Journal of neuroscience: the official journal of the Society for Neuroscience, 18, 451 (1998)
  52. Rodríguez-Muñoz María, de la Torre-Madrid Elena, Sánchez-Blázquez Pilar, Garzón Javier, Morphine Induces Endocytosis of Neuronal μ-opioid Receptors Through the Sustained Transfer of Gα Subunits to RGSZ2 Proteins, 10.1186/1744-8069-3-19
  53. Romero-Sandoval Alfonso, Nutile-McMenemy Nancy, DeLeo Joyce A., Spinal Microglial and Perivascular Cell Cannabinoid Receptor Type 2 Activation Reduces Behavioral Hypersensitivity without Tolerance after Peripheral Nerve Injury : , 10.1097/aln.0b013e318167af74
  54. Ruiz de Azua Inigo, Scarselli Marco, Rosemond Erica, Gautam Dinesh, Jou William, Gavrilova Oksana, Ebert Philip J., Levitt Pat, Wess Jürgen, RGS4 is a negative regulator of insulin release from pancreatic β-cells in vitro and in vivo, 10.1073/pnas.1003655107
  55. Scholz Joachim, Woolf Clifford J, The neuropathic pain triad: neurons, immune cells and glia, 10.1038/nn1992
  56. Schwendt Marek, Sigmon Stacey A., McGinty Jacqueline F., RGS4 overexpression in the rat dorsal striatum modulates mGluR5- and amphetamine-mediated behavior and signaling, 10.1007/s00213-011-2606-8
  57. Seltzer Zeʼev, Dubner Ronald, Shir Yoram, A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury : , 10.1016/0304-3959(90)91074-s
  58. Song K. S., Choi Y. H., Kim J.-M., Lee H., Lee T.-J., Yoon J.-H., Suppression of prostaglandin E2-induced MUC5AC overproduction by RGS4 in the airway, 10.1152/ajplung.90396.2008
  59. Starowicz Katarzyna, Makuch Wioletta, Korostynski Michal, Malek Natalia, Slezak Michal, Zychowska Magdalena, Petrosino Stefania, De Petrocellis Luciano, Cristino Luigia, Przewlocka Barbara, Di Marzo Vincenzo, Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism, 10.1371/journal.pone.0060040
  60. Stratinaki M., Varidaki A., Mitsi V., Ghose S., Magida J., Dias C., Russo S. J., Vialou V., Caldarone B. J., Tamminga C. A., Nestler E. J., Zachariou V., Regulator of G protein signaling 4 is a crucial modulator of antidepressant drug action in depression and neuropathic pain models, 10.1073/pnas.1214696110
  61. Sutor Sarah, Heilmann Jörg, Seifert Roland, Impact of fusion to Gαi2and co-expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB1R and CB2R : Cannabinoid receptors and RGS proteins, 10.1111/j.2042-7158.2011.01307.x
  62. Tao, The Journal of neuroscience: the official journal of the Society for Neuroscience, 23, 6703 (2003)
  63. Tokudome T., Kishimoto I., Horio T., Arai Y., Schwenke D. O., Hino J., Okano I., Kawano Y., Kohno M., Miyazato M., Nakao K., Kangawa K., Regulator of G-Protein Signaling Subtype 4 Mediates Antihypertrophic Effect of Locally Secreted Natriuretic Peptides in the Heart, 10.1161/circulationaha.107.732990
  64. Tovey S. C., Single-Cell Imaging of Intracellular Ca2+ and Phospholipase C Activity Reveals That RGS 2, 3, and 4 Differentially Regulate Signaling via the G q/11-Linked Muscarinic M3 Receptor, 10.1124/mol.104.005827
  65. van Hecke O., Austin Sophie K., Khan Rafi A., Smith B. H., Torrance N., Neuropathic pain in the general population: A systematic review of epidemiological studies : , 10.1016/j.pain.2013.11.013
  66. Walker J. M., Huang S. M., Strangman N. M., Tsou K., Sanudo-Pena M. C., Pain modulation by release of the endogenous cannabinoid anandamide, 10.1073/pnas.96.21.12198
  67. Wallace, The Journal of neuroscience: the official journal of the Society for Neuroscience, 23, 3221 (2003)
  68. Wang Wei, Petralia Ronald S, Takamiya Kogo, Xia Jun, Li Yun-Qing, Huganir Richard L, Tao Yuan-Xiang, Yaster Myron, Preserved Acute Pain and Impaired Neuropathic Pain in Mice Lacking Protein Interacting with C Kinase 1, 10.1186/1744-8069-7-11
  69. Wilkerson Jenny L., Gentry Katherine R., Dengler Ellen C., Wallace James A., Kerwin Audra A., Armijo Leisha M., Kuhn Megan N., Thakur Ganesh A., Makriyannis Alexandros, Milligan Erin D., Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels : , 10.1016/j.pain.2012.02.015
  70. Wu Sheng-Xi, Wang Wen, Li Hui, Wang Ya-Yun, Feng Yu-Peng, Li Yun-Qing, The synaptic connectivity that underlies the noxious transmission and modulation within the superficial dorsal horn of the spinal cord, 10.1016/j.pneurobio.2010.01.005
  71. Zachariou V., Georgescu D., Sanchez N., Rahman Z., DiLeone R., Berton O., Neve R. L., Sim-Selley L. J., Selley D. E., Gold S. J., Nestler E. J., Essential role for RGS9 in opiate action, 10.1073/pnas.2232594100
  72. Zhuang Z.-Y., A Peptide c-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance, 10.1523/jneurosci.5290-05.2006